Profile | GDS4284 / 1564257_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 123.162 | 41 |
GSM687648 | Patient 402 control | 159.642 | 45 |
GSM687653 | Patient 403 control | 94.9533 | 35 |
GSM687658 | Patient 404 control | 67.4749 | 27 |
GSM687663 | Patient 411 control | 105.144 | 34 |
GSM687668 | Patient 422 control | 54.9668 | 25 |
GSM687673 | Patient 424 control | 203.398 | 47 |
GSM687678 | Patient 425 control | 25.9306 | 14 |
GSM687683 | Patient 427 control | 77.1842 | 28 |
GSM687688 | Patient 428 control | 103.509 | 35 |
GSM687695 | Patient 441 control | 35.4538 | 11 |
GSM687699 | Patient 443 control | 172.19 | 41 |
GSM687704 | Patient 444 control | 202.959 | 49 |
GSM687707 | Patient 448 control | 222.039 | 47 |
GSM687712 | Patient 449 control | 123.91 | 38 |
GSM687719 | Patient 450 control | 129.996 | 36 |
GSM687724 | Patient 451 control | 208.476 | 47 |
GSM687728 | Patient 452 control | 106.997 | 33 |
GSM687646 | Patient 401 treated 24h | 128.059 | 39 |
GSM687649 | Patient 402 treated 24h | 98.8536 | 36 |
GSM687665 | Patient 411 treated 24h | 145.848 | 40 |
GSM687651 | Patient 402 treated 4 weeks | 92.732 | 32 |
GSM687667 | Patient 411 treated 4 weeks | 114.575 | 37 |
GSM687670 | Patient 422 treated 24h | 86.4892 | 31 |
GSM687671 | Patient 422 treated 4 weeks | 117.02 | 38 |
GSM687654 | Patient 403 treated 24h | 87.5983 | 34 |
GSM687675 | Patient 424 treated 24h | 191.081 | 45 |
GSM687685 | Patient 427 treated 24h | 169.676 | 45 |
GSM687656 | Patient 403 treated 4 weeks | 78.5684 | 32 |
GSM687677 | Patient 424 treated 4 weeks | 114.345 | 37 |
GSM687687 | Patient 427 treated 4 weeks | 135.802 | 43 |
GSM687692 | Patient 428 treated 4h | 133.676 | 40 |
GSM687716 | Patient 449 treated 4h | 182.103 | 47 |
GSM687722 | Patient 450 treated 4h | 136.387 | 37 |
GSM687680 | Patient 425 treated 24h | 76.4326 | 30 |
GSM687690 | Patient 428 treated 24h | 123.944 | 39 |
GSM687700 | Patient 443 treated 24h | 37.2189 | 13 |
GSM687705 | Patient 444 treated 24h | 104.835 | 37 |
GSM687714 | Patient 449 treated 24h | 73.6327 | 30 |
GSM687721 | Patient 450 treated 24h | 86.8875 | 28 |
GSM687682 | Patient 425 treated 4 weeks | 116.343 | 38 |
GSM687694 | Patient 428 treated 4 weeks | 73.9555 | 30 |
GSM687702 | Patient 443 treated 4 weeks | 125.575 | 37 |
GSM687718 | Patient 449 treated 4 weeks | 119.748 | 37 |
GSM687723 | Patient 450 treated 4 weeks | 126.659 | 38 |
GSM687661 | Patient 404 treated 4h | 69.5736 | 27 |
GSM687710 | Patient 448 treated 4h | 95.6208 | 33 |
GSM687726 | Patient 451 treated 4h | 58.7463 | 23 |
GSM687730 | Patient 452 treated 4h | 410.404 | 50 |
GSM687660 | Patient 404 treated 24h | 125.724 | 34 |
GSM687697 | Patient 441 treated 24h | 145.888 | 35 |
GSM687709 | Patient 448 treated 24h | 41.011 | 19 |
GSM687725 | Patient 451 treated 24h | 130.125 | 35 |
GSM687729 | Patient 452 treated 24h | 132.956 | 33 |
GSM687727 | Patient 451 treated 4 weeks | 135.755 | 37 |
GSM687731 | Patient 452 treated 4 weeks | 101.739 | 32 |